The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...
As a Nasdaq-listed company, Oxbridge Re, through its subsidiary SurancePlus Inc., became the first public company to issue a security token in reinsurance-bridging the gap between the SEC, blockchain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback